Year: 2006
Type: review
Abstract: Targeting the nuclear receptors: The ligand-binding domain of the glucocorticoid receptor (ribbon) bound with the ligand, dexamethasone (space-filling) is just one of the many pictures that are becoming clearer in the field of nuclear receptor (NR) research. Recent developments in drug discovery show great promise for the treatment of many NR-related diseases.
Source: ChemMedChem
Institution: GlaxoSmithKline (United States)
Language: English
Subfield: Endocrinology
Domain: Life Sciences
Open Access status: bronze
OpenAlex ID: W2146222477
